World Congress of Endourology (WCE) 2019

World Congress of Endourology (WCE) 2019 is organized by Emirates Urological Society (EUS), Urology Management Services (UMS), Endourological Society and will be held from Oct 29 - Nov 02, 2019 at Abu Dhabi National Exhibition Centre, Abu Dhabi, United Arab Emirates.

Target Audience:
The primary target audience includes:
• Practicing urologists in academic and private practice
• Non-practicing urologists
• Urology residents
• Urology fellows
• Medical students
• Other health professionals (i.e. Ph.D.’s and nurses involved in urologic research and patient care

Accreditation:
The American Urological Association designates this live activity for a maximum of 27.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Course Purpose:
The World Congress of Endourology, provided by the Endourological Society Inc., is the largest meeting in the world that focuses on minimally invasive urologic surgery and encompasses endourologic, laparoscopic, robotic and other technologic interventions as well as medical management for urologic conditions. The meeting is an annual international conference that comprises the premier minimally invasive gathering within the field of urology.

Join us in the breathtaking and modern city of Abu Dhabi, the capital of the United Arab Emirates, for the 37th World Congress of Endourology, the world’s foremost meeting dedicated to minimally invasive urologic surgery, held in conjunction with the 8th Emirates Urological Society Conference (EUSC 2019). Assembling the global leaders of today, WCE 2019 will provide unparalleled opportunities to expand your education, enhance your skills and exchange ideas.

Learning Objectives:
After attending this activity, participants should be able to:
• Describe recent developments in the medical management, non-invasive and minimally invasive surgical management of urologic diseases.
• Integrate the latest guidelines on the management of urologic conditions into clinical practice.
• Identify new technologies for the management of benign and malignant urologic conditions.
• Incorporate new techniques into surgical practice for a variety of urologic problems.
• Analyze outcome data and critically appraise medical and surgical options for the treatment of urologic conditions.

Additional details will be posted as soon as information is available.